Shalinsky, David R. External Entity

Publications

Sort by

Selected publications

  • Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology2008 Academic Article GET IT
    Times cited: 423

Other